ARIEL LE: Open Payments
NPI 1730690991 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 25 payments from 16 companies in 2025. Trend: 2023 $3,326 · 2024 $3,946 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| PFIZER INC. | 3 | $58 |
| Biogen, Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $35 |
| ABBVIE INC. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Eisai Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
Products named: KESIMPTA, NURTEC ODT, TYSABRI, INGREZZA, PURIFIED CORTROPHIN GEL, HYQVIA, Leqembi, Apokyn.
Industry payments across FL — which companies pay providers there.
